SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013368
Filing Date
2022-05-13
Accepted
2022-05-13 17:03:23
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 791090
2 ex31-1.htm EX-31.1 19606
3 ex31-2.htm EX-31.2 19524
4 ex32-1.htm EX-32.1 7507
5 ex32-2.htm EX-32.2 7557
  Complete submission text file 0001493152-22-013368.txt   4378042

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT foxw-20220331.xsd EX-101.SCH 34638
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT foxw-20220331_cal.xml EX-101.CAL 37058
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT foxw-20220331_def.xml EX-101.DEF 203979
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT foxw-20220331_lab.xml EX-101.LAB 264290
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT foxw-20220331_pre.xml EX-101.PRE 231823
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 677110
Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020 917-284-8938
FoxWayne Enterprises Acquisition Corp. (Filer) CIK: 0001829999 (see all company filings)

IRS No.: 853093926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39891 | Film No.: 22923808
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences